| 201 |
16765099 | Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists. | 2006 Sep |
1 |
| 202 |
16800161 | Cost-effectiveness of rosiglitazone oral combination for the treatment of type 2 diabetes in Germany. | 2006 |
2 |
| 203 |
16800162 | Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain. | 2006 |
2 |
| 204 |
16804037 | Low-dose rosiglitazone exerts an antiinflammatory effect with an increase in adiponectin independently of free fatty acid fall and insulin sensitization in obese type 2 diabetics. | 2006 Sep |
5 |
| 205 |
16822823 | The Pro12Ala variant of the PPARG gene is a risk factor for peroxisome proliferator-activated receptor-gamma/alpha agonist-induced edema in type 2 diabetic patients. | 2006 Sep |
1 |
| 206 |
16896939 | Insulin sensitisation affects lipoprotein lipase transport in type 2 diabetes: role of adipose tissue and skeletal muscle in response to rosiglitazone. | 2006 Oct |
1 |
| 207 |
16914073 | Metformin and pioglitazone: Effectively treating insulin resistance. | 2006 |
1 |
| 208 |
16932451 | Do patients with type 2 diabetes on peritoneal dialysis need less insulin if they are given rosiglitazone? | 2006 Jun |
1 |
| 209 |
16997664 | Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. | 2006 Sep 23 |
2 |
| 210 |
17039655 | Comparison of metformin versus rosiglitazone in patients with Acanthosis nigricans: a pilot study. | 2006 Oct |
2 |
| 211 |
17145645 | Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome? | 2006 Nov |
1 |
| 212 |
17294577 | [Experiences of the DREAM trial]. | 2006 Dec 31 |
2 |
| 213 |
17345784 | Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha. | 2006 Nov |
1 |
| 214 |
15386806 | Rosiglitazone combined with insulin preserves islet beta cell function in adult-onset latent autoimmune diabetes (LADA). | 2005 Mar-Apr |
1 |
| 215 |
15483106 | Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance. | 2005 Jan |
7 |
| 216 |
15615809 | Short-term treatment with rosiglitazone improves glucose tolerance, insulin sensitivity and endothelial function in renal transplant recipients. | 2005 Feb |
3 |
| 217 |
15617852 | Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property. | 2005 |
1 |
| 218 |
15620433 | Predictive clinical parameters for therapeutic efficacy of rosiglitazone in Korean type 2 diabetes mellitus. | 2005 Jan |
2 |
| 219 |
15638875 | Rosiglitazone improves insulin sensitivity and glucose tolerance in subjects with impaired glucose tolerance. | 2005 Jan |
6 |
| 220 |
15654920 | The brown adipose cell: a model for understanding the molecular mechanisms of insulin resistance. | 2005 Jan |
5 |
| 221 |
15700135 | Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression. | 2005 Mar |
1 |
| 222 |
15704569 | [Glucose-independent impact of the glitazones on the cardiovascular outcome]. | 2005 Jan 13 |
1 |
| 223 |
15736108 | The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus. | 2005 Mar |
1 |
| 224 |
15751771 | Influence of rosiglitazone on flow-mediated dilation and other markers of cardiovascular risk in HIV-infected patients with lipoatrophy. | 2005 |
2 |
| 225 |
15773972 | Rosiglitazone is a safe and effective treatment option of new-onset diabetes mellitus after renal transplantation. | 2005 Apr |
1 |
| 226 |
15787606 | Modulation of insulin signalling by insulin sensitizers. | 2005 Apr |
1 |
| 227 |
15837949 | Insulin-mediated upregulation of the renin angiotensin system in human subcutaneous adipocytes is reduced by rosiglitazone. | 2005 Apr 19 |
4 |
| 228 |
15842531 | Rosiglitazone improves insulin sensitivity, glucose tolerance and ambulatory blood pressure in subjects with impaired glucose tolerance: does it really work? If yes, is it a novelty? | 2005 May |
1 |
| 229 |
15844237 | Insulin resistance, HIV infection, and anti-HIV therapies. | 2005 Apr |
1 |
| 230 |
15855323 | Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma. | 2005 May |
2 |
| 231 |
15855334 | Effects of metformin and rosiglitazone treatment on insulin signaling and glucose uptake in patients with newly diagnosed type 2 diabetes: a randomized controlled study. | 2005 May |
4 |
| 232 |
15864539 | Enhanced insulin-stimulated glycogen synthesis in response to insulin, metformin or rosiglitazone is associated with increased mRNA expression of GLUT4 and peroxisomal proliferator activator receptor gamma co-activator 1. | 2005 Jun |
3 |
| 233 |
15877288 | Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty. | 2005 May |
5 |
| 234 |
15899724 | Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome. | 2005 May |
3 |
| 235 |
15938589 | Long-term effect of glimepiride and rosiglitazone on non-conventional cardiovascular risk factors in metformin-treated patients affected by metabolic syndrome: a randomized, double-blind clinical trial. | 2005 May-Jun |
2 |
| 236 |
15955124 | The effect of metformin and rosiglitazone on postprandial lipid metabolism in obese insulin-resistant subjects. | 2005 Jul |
3 |
| 237 |
15983223 | Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients. | 2005 Jul |
1 |
| 238 |
15994753 | Effect of rosiglitazone on insulin resistance, C-reactive protein and endothelial function in non-obese young women with polycystic ovary syndrome. | 2005 Jul |
2 |
| 239 |
16006724 | Endocrine and metabolic effects of rosiglitazone in non-obese women with polycystic ovary disease. | 2005 Jun |
2 |
| 240 |
16025252 | Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol. | 2005 Sep |
1 |
| 241 |
16117910 | [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences]. | 2005 Aug 22 |
1 |
| 242 |
16126119 | Rosiglitazone effects on blood pressure and metabolic parameters in nondipper diabetic patients. | 2005 Oct |
2 |
| 243 |
16131582 | Direct thiazolidinedione action in the human ovary: insulin-independent and insulin-sensitizing effects on steroidogenesis and insulin-like growth factor binding protein-1 production. | 2005 Nov |
3 |
| 244 |
16183427 | Rosiglitazone reduces insulin requirement and C-reactive protein levels in type 2 diabetic patients receiving peritoneal dialysis. | 2005 Oct |
7 |
| 245 |
16189256 | Rosiglitazone treatment increases subcutaneous adipose tissue glucose uptake in parallel with perfusion in patients with type 2 diabetes: a double-blind, randomized study with metformin. | 2005 Dec |
4 |
| 246 |
16200335 | Effect of metformin and rosiglitazone on lipid metabolism in HIV infected patients receiving protease inhibitor containing HAART. | 2005 Sep |
4 |
| 247 |
16219007 | Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus. | 2005 Nov |
2 |
| 248 |
16219011 | Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones. | 2005 Nov |
1 |
| 249 |
16231594 | The treatment of NAFLD. | 2005 Sep-Oct |
1 |
| 250 |
16259488 | Discrepancies in the regulation of plasma adiponectin and TNF-alpha levels and adipose tissue gene expression in obese African Americans with glucose intolerance: a pilot study using rosiglitazone. | 2005 Autumn |
2 |